Publications scientifiques
Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).
-
Pneumopathies interstitielles diffuses (PID)
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
JAMA Netw Open. 2022 Nov 1;5(11):e2243799.
-
Pneumopathies interstitielles diffuses (PID)
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Respir Med Res. 2022 Nov 30;83:100946.
-
Pneumopathies interstitielles diffuses (PID)
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1293-1294.
-
Pneumopathies interstitielles diffuses (PID)
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Rheumatology (Oxford). 2022 Nov 2;61(11):4397-4408.
-
Pneumopathies interstitielles diffuses (PID)
Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study.
Ann Thorac Surg. 2022 Nov;114(5):1911-1917.
-
Pneumopathies interstitielles diffuses (PID)
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Ann Rheum Dis. 2022 Dec;81(12):1722-1729.
-
Pneumopathies interstitielles diffuses (PID)
Progressive pulmonary fibrosis: an expert group consensus statement.
Eur Respir J. 2022 Dec 14:2103187.
-
Pneumopathies interstitielles diffuses (PID)
Pleuroparenchymal fibroelastosis: so many unmet needs.
Eur Respir J. 2022 Dec 22;60(6):2201798.
-
Pneumopathies interstitielles diffuses (PID)
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease.
J Autoimmun. 2022 Dec;133:102941.
-
Pneumopathies interstitielles diffuses (PID)
Lung cancer in pulmonary fibrosis: no room for nihilism!
Eur Respir J. 2022 Dec 15;60(6):2201946.